Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 2
2016 2
2017 3
2018 2
2019 2
2020 1
2021 5
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice.
Gonzalo-Consuegra C, Santos-García I, García-Toscano L, Martín-Baquero R, Rodríguez-Cueto C, Wittwer MB, Dzygiel P, Grether U, de Lago E, Fernández-Ruiz J. Gonzalo-Consuegra C, et al. Among authors: rodriguez cueto c. Biomed Pharmacother. 2024 Mar 23;174:116473. doi: 10.1016/j.biopha.2024.116473. Online ahead of print. Biomed Pharmacother. 2024. PMID: 38522237 Free article.
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice.
Santos-García I, Rodríguez-Cueto C, Villegas P, Piscitelli F, Lauritano A, Shen CJ, Di Marzo V, Fernández-Ruiz J, de Lago E. Santos-García I, et al. Among authors: rodriguez cueto c. J Neuroinflammation. 2023 May 6;20(1):108. doi: 10.1186/s12974-023-02792-z. J Neuroinflammation. 2023. PMID: 37149645 Free PMC article.
Editorial: Cannabinoids as potential treatment for neurological diseases.
Gómez-Cañas M, Morales P, Satta V, Rodríguez-Cueto C, García C, Sagredo O. Gómez-Cañas M, et al. Among authors: rodriguez cueto c. Front Neurosci. 2022 Dec 20;16:1108101. doi: 10.3389/fnins.2022.1108101. eCollection 2022. Front Neurosci. 2022. PMID: 36605545 Free PMC article. No abstract available.
Endocannabinoid-Binding Receptors as Drug Targets.
Gómez-Cañas M, Rodríguez-Cueto C, Satta V, Hernández-Fisac I, Navarro E, Fernández-Ruiz J. Gómez-Cañas M, et al. Among authors: rodriguez cueto c. Methods Mol Biol. 2023;2576:67-94. doi: 10.1007/978-1-0716-2728-0_6. Methods Mol Biol. 2023. PMID: 36152178
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.
Burgaz S, García C, Gonzalo-Consuegra C, Gómez-Almería M, Ruiz-Pino F, Unciti JD, Gómez-Cañas M, Alcalde J, Morales P, Jagerovic N, Rodríguez-Cueto C, de Lago E, Muñoz E, Fernández-Ruiz J. Burgaz S, et al. Among authors: rodriguez cueto c. Molecules. 2021 Dec 16;26(24):7643. doi: 10.3390/molecules26247643. Molecules. 2021. PMID: 34946726 Free PMC article.
Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment.
Martínez-González L, Rodríguez-Cueto C, Cabezudo D, Bartolomé F, Andrés-Benito P, Ferrer I, Gil C, Martín-Requero Á, Fernández-Ruiz J, Martínez A, de Lago E. Martínez-González L, et al. Among authors: rodriguez cueto c. Sci Rep. 2020 Mar 10;10(1):4449. doi: 10.1038/s41598-020-61265-y. Sci Rep. 2020. PMID: 32157143 Free PMC article.
21 results